Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2024Blood AdvancesOpen Access

Haploidentical transplantation in primary refractory/relapsed secondary versus de novo AML: from the ALWP/EBMT

View Full Paper
Ask AI
Bookmark
Share

Authors

Arnon NaglerArnon NaglerGoethe University FrankfurtMLMyriam LabopinInsermJTJohanna TischerTU Wien

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nagler et al. (2024) studied this question.

synapsesocial.com/papers/68e5c757b6db64358755deefhttps://doi.org/10.1182/bloodadvances.2024012798
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation2009 · 534 citations
  2. 2Testing for centre effects in multi‐centre survival studies: a Monte Carlo comparison of fixed and random effects tests1999 · 229 citations
  3. 3Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia2020 · 66 citations
  4. 4Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis2022 · 44 citations
  5. 5Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study2018 · 61 citations